USANA Health Sciences (NYSE:USNA) vs. Interparfums (NASDAQ:IPAR) Head to Head Comparison

Interparfums (NASDAQ:IPAR) and USANA Health Sciences (NYSE:USNA) are both consumer staples companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, risk, earnings, valuation and institutional ownership.

Earnings & Valuation

This table compares Interparfums and USANA Health Sciences”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Interparfums	$1.49 billion	2.68	$168.39 million	$5.27	23.70
USANA Health Sciences	$925.26 million	0.46	$10.76 million	$0.47	48.72

Interparfums has higher revenue and earnings than USANA Health Sciences. Interparfums is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Interparfums and USANA Health Sciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Interparfums	11.32%	15.47%	10.82%
USANA Health Sciences	0.96%	6.21%	4.50%

Insider and Institutional Ownership

55.6% of Interparfums shares are owned by institutional investors. Comparatively, 54.2% of USANA Health Sciences shares are owned by institutional investors. 43.7% of Interparfums shares are owned by company insiders. Comparatively, 0.8% of USANA Health Sciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Volatility and Risk

Interparfums has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500. Comparatively, USANA Health Sciences has a beta of 0.73, meaning that its stock price is 27% less volatile than the S&P 500.

Analyst Ratings

This is a summary of recent ratings for Interparfums and USANA Health Sciences, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Interparfums	0	3	4	1	2.75
USANA Health Sciences	1	1	0	0	1.50

Interparfums currently has a consensus price target of $116.17, suggesting a potential downside of 7.01%. Given Interparfums’ stronger consensus rating and higher possible upside, equities analysts clearly believe Interparfums is more favorable than USANA Health Sciences.

Summary

Interparfums beats USANA Health Sciences on 14 of the 15 factors compared between the two stocks.

About Interparfums

Inter Parfums, Inc., together with its subsidiaries, manufactures, markets, and distributes a range of fragrances and fragrance related products in the United States and internationally. It operates in two segments, European Based Operations and United States Based Operations. The company offers its fragrance and cosmetic products under the Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lanvin, Moncler, Montblanc, Rochas, S.T. Dupont, Van Cleef & Arpels, Abercrombie & Fitch, Anna Sui, Donna Karan, DKNY, Emanual Ungaro, Ferragamo, Graff, GUESS, Hollister, MCM, Oscar de la Renta, Ungaro, and Roberto Cavalli brands, as well as French Connection, Intimate, and Dunhill, Lacoste names. It sells its products to department stores, perfumeries, specialty stores, duty free shops, and domestic and international wholesalers, and distributors, as well as through e-commerce. The company was formerly known as Jean Philippe Fragrances, Inc. and changed its name to Inter Parfums, Inc. in July 1999. Inter Parfums, Inc. was founded in 1982 and is headquartered in New York, New York.

About USANA Health Sciences

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.